FDA Issues Ethical Guidance to Protect Children who Participate in Clinical Trials

Rare Daily Staff The U.S. Food and Drug Administration issued a draft guidance to assist industry, sponsors and institutional review

Read More
FDA Places Clinical Hold on Pharvaris HAE Clinical Trials in the United States

Rare Daily Staff Pharvaris said the U.S. Food and Drug Administration verbally informed the company that, based on its review

Read More
ProQR Winds Down Clinical Trials to Focus Exclusively on Axiomer RNA-editing Technology

Rare Daily Staff ProQR Therapeutics, following the European Medicines Agency recommendation that the company conduct an additional phase 3 study

Read More
Designing Clinical Trials with the Patient in Mind

Jenn McNary is a mother of children with rare conditions, as well as an outspoken advocate who has sought to

Read More
Keeping Clinical Trials Running Smoothly

Clinical trials can get derailed for a variety of reasons that may have nothing to do with whether a drug

Read More
RARE Drug Development Symposium: Disruptive Innovations in Clinical Trials Workshop

The 2022 RARE Drug Development Symposium kicks off June 8, and Global Genes is ecstatic about the speaker lineup for

Read More
Getting Your Community Ready for Clinical Trials

Helping patients and caregivers understand their options for clinical trials – and what to consider when making a decision on

Read More
BioCryst Pauses Enrollment in BCX9930 Clinical Trials

Rare Daily Staff In a two-sentence statement, BioCryst Pharmaceuticals said it had paused enrollment in three clinical trials of its

Read More
FDA Awards 11 Grants to Clinical Trials to Develop New Medical Products for Rare Disease Treatments

Rare Daily Staff The U.S. Food and Drug Administration has awarded 11 new clinical trial research grants totaling more than

Read More
IndoUSrare Webinar “Clinical Trials: The Hope to Cure Rare Diseases” by Mohamed Duklef

We are incredibly excited to present to you, “Clinical Trials: The Hope to Cure Rare Diseases” by Mohamed Duklef. The

Read More
Stealth Bio Raises $30 Million to Advance Elamipretide Clinical Trials

Rare Daily Staff Stealth BioTherapeutics, a clinical-stage biotechnology company focused discovering, developing, and commercializing novel therapies for diseases involving mitochondrial

Read More
Putting the Patient at the Center of Rare Disease Clinical Trials

The recruitment of patients for rare disease clinical trials can be challenging because of issues such as small patient populations

Read More
Load More
X